January 3 However, a global study co-led by the London School of Hygiene & Tropical Medicine and Monash University in Australia, has shown that people who are seeking PrEP to prevent HIV are also at high risk of other sexually transmitted infections (STIs). Supported by the World Health Organization, the study, published in JAMA Open ... Read More
December 19 Significantly more gay and bisexual men are using HIV pre-exposure prophylaxis (PrEP) due to increased confidence in the benefits of HIV treatment for prevention. The number of gay and bisexual men using PrEP to prevent HIV infection has almost doubled in the last two years. The number of gay and bisexual men using ... Read More
November 21, 2019 A new study from the Kirby Institute at UNSW Sydney published today shows that gay and bisexual men who are taking the HIV prevention medication PrEP (pre-exposure prophylaxis) also have significantly lower levels of HIV-related anxiety. HIV transmission anxiety has affected sexual behaviours of gay and bisexual men for more than 30 years, but ... Read More
November 7, 2019 Transgender women—people born male who identify as women—are the population most at risk for HIV. They are also the most understudied population. “We need to find out who they are, how old they are, where they live, where they work, what’s their lifestyle,” says Dr. Cheryl Holder, an HIV specialist and associate ... Read More
July 24, 2019 An implant containing an HIV-prevention drug has been trialed in humans, in a step experts have hailed as an exciting development in curtailing infections. Pre-exposure prophylaxis, or PrEP, with antiretroviral drugs has become a hot topic in recent years, with the drugs shown to substantially reduce the risk of contracting HIV from ... Read More
July 23 2019 Representatives from the World Health Organisation (WHO) have released the results of an extensive review, highlighting an opportunity for PrEP programs to bring down incidences of other STIs with better integration and coordination. Speaking at the 10th International AIDS Society Conference on HIV Science in Mexico City, ... Read More
May 16, 2019 Last year Aotearoa New Zealand became one of the first countries in the world to publicly fund the HIV prevention drug called pre-exposure prophylaxis or “PrEP”. We desperately needed that decision – it followed our worst ever year of the HIV epidemic, with 244 new diagnoses. PrEP virtually eliminates the risk of ... Read More
May 7, 2019 Bradley van Paridon An increased incidence of sexually transmitted infections (STIs) was associated with the receipt of HIV pre-exposure prophylaxis (PrEP) in gay and bisexual men, according to data published in JAMA. To describe the STI incidence and behavioral risk factors in a cohort of gay and bisexual men using PrEP and ... Read More
March 25, 2019 About 19,000 Australians have taken advantage of anti-HIV drugs in the first two years of groundbreaking PrEP regimen being subsidised via the Pharmaceutical Benefits Scheme. Researchers point to the increasing number of HIV-positive Australians starting early antiretroviral treatment to prevent its development and spread. The latest surveillance ... Read More
5 MARCH 2019 Anne Gulland, global health security correspondent and Sarah Newey The news that a man in London has potentially been “cured” of HIV through a stem cell transplant shows how far the world has come since Aids first burst into global consciousness in the 1980s. HIV is thought to have originated in the 1920s in ... Read More
